Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 32 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

6%

2 trials in Phase 3/4

Results Transparency

0%

0 of 15 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
17(73.9%)
Phase 2
3(13.0%)
Phase 3
1(4.3%)
Phase 1
1(4.3%)
Phase 4
1(4.3%)
23Total
N/A(17)
Phase 2(3)
Phase 3(1)
Phase 1(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (32)

Showing 20 of 32 trials
NCT06653192Not ApplicableSuspended

EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction (CARPEDIEM Trial)

Role: collaborator

NCT06375967Not ApplicableSuspended

EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)

Role: collaborator

NCT05834309Not ApplicableActive Not Recruiting

Exercise Effects on Health Status in Patients With Severe Mental Illness

Role: collaborator

NCT06048757Not ApplicableCompleted

Mobile Application-delivered Resistance Program for Children and Adolescents With Type 1 Diabetes (Diactive-1)

Role: collaborator

NCT07264231Not ApplicableEnrolling By Invitation

Exercise During Pregnancy: Effects on the Maternal-Fetal Unit

Role: collaborator

NCT07251361Not ApplicableEnrolling By Invitation

Effects of a Multicomponent Training Program on Cardiac Function, Skeletal Muscle Metabolism, Functional Capacity, and Quality of Life in Patients With HFpEF: SENSORFIT-4HEART Study

Role: collaborator

NCT05953259Not ApplicableActive Not Recruiting

RCT to Evaluate STERN FIX Device as a Sternal Stabilization System in Patients After Sternotomy

Role: collaborator

NCT04575506Not ApplicableCompleted

Influence of the Diversity and Composition of the Microbiota in the Development of Pediatric Fatty Liver

Role: collaborator

NCT06099119Phase 4Recruiting

Efficacy of PERT for PEI in Unresectable Pancreatic Cancer.

Role: collaborator

NCT06956729Not ApplicableRecruiting

Multicenter Trial of Proximal Femoral Guided Growth in Children With CP and Hips at Risk of Dislocation (GGSH-MC)

Role: collaborator

NCT06944327Not ApplicableNot Yet Recruiting

Reduction of Complications Associated With PICC Management

Role: collaborator

NCT03868046Completed

Autoantibodies in Treatment with Immune Checkpoint Inhibitors (AUTENTIC)

Role: collaborator

NCT06375928Not ApplicableNot Yet Recruiting

EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction in Resectable Disease (CARPEDIEM-1 Trial)

Role: collaborator

NCT06375954Not ApplicableNot Yet Recruiting

EUS-guided CDS vs ERCP as First Line in Malignant Distal Obstruction in Borderline Disease (CARPEDIEM-2 Trial)

Role: collaborator

NCT05349851Unknown

Bowel Cleansing With Renal Impairment

Role: collaborator

NCT04797871Not ApplicableCompleted

Resistance Training and Clinical Status in Patients With Post Discharge Symptoms After Covid-19

Role: collaborator

NCT03773445Completed

Golimumab Trough Levels in Patients With Ulcerative Colitis

Role: collaborator

NCT03617133Phase 2Recruiting

Image Guided IMRT, Radiochemotherapy and MRI-based IGABT in Locally Advanced Cervical Cancer

Role: collaborator

NCT04663893Recruiting

Peri-Implant and Peri-Prosthetic Fractures: Epidemiology, Morbidity, Mortality, Treatment and Outcome Analysis

Role: collaborator

NCT04600453Not ApplicableCompleted

Prevention of Functional and Cognitive Impairment Through a Multicomponent Exercise Program

Role: collaborator